FDA expands use of Zika screening test
The US Food and Drug Administration (FDA) approved an additional claim for the cobas Zika test, manufactured by Roche Molecular Diagnostics, the company announced today in a news release. The approval allows the test to be used to screen pooled blood and plasma donations for the Zika virus.
According to Roche, the new application will streamline the screening process of multiple individual blood or plasma donations.